Vγ9/Vδ2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis

European Journal of Immunology

Volumn 30, Issue 5, 2000, Pages 1512-1519

  Dieli, Francesco ^a   Troye Blomberg, Marita ^b   Ivanyi, Juraj ^c   Fournié, Jean Jacques ^d   Bonneville, Marc ^e   Peyrat, Marie Alix ^e   Sireci, Guido ^a   Salerno, Alfredo ^a,f  

^a UNIVERSITY OF PALERMO   (Italy)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CHU PURPAN   (France)

^e INSTITUT DE BIOLOGIE   (France)

^f CNR   (Italy)

Author keywords

Killing; Macrophage; Mycobacterium tuberculosis; Perforin; V 9 V 2 cells

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL IMMUNITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; TUBERCULOSIS;

CELLS, CULTURED; HUMANS; IMMUNITY, NATURAL; LYMPHOCYTE ACTIVATION; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MYCOBACTERIUM TUBERCULOSIS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0033625646     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200005)30:5<1512::AID-IMMU1512>3.0.CO;2-3     Document Type: Article

References (49)

1. Snider, D. E., Raviglione, M. and Kochi, A., Global burden of tuberculosis. In Bloom, B. R. (Ed.) Tuberculosis: Pathogenesis. Protection and Control. ASM Press, Washington DC 1994, pp. 3-10.
2. Mackaness, G. B., The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J. Exp. Med. 1969. 129: 973-978.
3. North, R. J., T cell dependence of macrophage activation and mobilisation during infection with Mycobacterium tuberculosis. Infect. Immun. 1974. 10: 66-71.
4. Kaufmann, S. H. E., In vitro analysis of the cellular mechanisms involved in immunity to tuberculosis. Rev. Infect. Dis. 1989. 11: 48-53.
5. Selwyn, P. A., Hartel, D., Lewis, V. A., Shoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T. and Friedland, G. H., A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 1989. 320: 545-549.
6. Hahn, H. and Kaufmann, S. H. E., The role of cell-mediated immunity in bacteria infections. Rev. Infect. Dis. 1981. 3: 1221-1250.
7. Rook, G. A., Champion, B. R., Steele, J., Varey, A. M. and Stanford, J. L., I-A restricted activation by T cell lines of antituberculosis activity in murine macrophages. Clin. Exp. Immunol. 1985. 59: 414-420.
8. Dannenberg, A. M., Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev. Inf. Dis. 1989. 2: 5369-5377.
9. Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J. P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R. and Modlin, R. L., Differential effect of cytolytic T cell subsets on intracellular infection. Science 1997. 276: 1684-1687.
10. Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melian, A., Bogdan, C., Porcelli, S. A., Bloom, B. R., Krensky, A. M. and Modlin, R. L., An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 1998. 282: 121-125.
11. Augustin, A., Kubo, R. T. and Sim, G. K., Resident pulmonary lymphocytes expressing the γ/δ T cell receptor. Nature 1989. 340: 329-332.
12. Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K. and Kaufmann, S. H. E., Protective role of γ/δ T cells and α/β T cells in tuberculosis. Eur. J. Immunol. 1995. 25: 2877-2881.
13. Saunders, B. M., Frank, A. A., Cooper, A. M. and Orme, I. M., Role of γδ T cells in immunopathology of pulmonary Mycobacterium avium infection n mice. Infect. Immun. 1998. 66: 5508-5514.
14. Kabelitz, D., Bender, A., Shondelmaier, S., Schoel, B. and Kaufmann, S. H. E., A large fraction of human peripheral blood γ/δ T cells is activated by Mycobacterium tuberculosis but not by its 65-KD heat shock protein. J. Exp. Med. 1990. 171: 667-679.
15. Kabelitz, D., Bender, A., Prospero, T., Wesselborg, S., Janssen, O. and Pechold, K., The primary response on human γ/δ T cells to Mycobacterium tuberculosis is restricted to Vγ9-bearing cells. J. Exp. Med. 1991. 173: 1331-1338.
16. Haregewoin, A., Soman, G., Hom, R. C. and Finberg, R. W., Human γδ T cells respond to mycobacterial heat shock protein. Nature 1989. 340:309-311,
17. Munk, M. E., Schoel, B., Modrow, A., Karr, R. W., Young, R. A. and Kaufmann, S. H. E., T lymphocytes from healthy individuals with specificity to self-epitopes shared by mycobacterial and human 65-kilodalton heat shock protein. J. Immunol. 1989. 143: 2844-2849.
18. Boom, W. H., Chervenak, K. A., Mincek, M. A. and Ellner, J. J., Role of the mononuclear phagocyte as an antigen-presenting cell for human γδ T cells activated by live Mycobacterium tuberculosis. Infect. Immun. 1992. 60: 3480-3488.
19. Lefranc, M. P., Forster, A., Baer, R., Stinson, M. A. and Rabbitts, T. H., Diversity and rea-rangement of the human T cell rearranging γ genes: nine germline variable genes belonging to two subgroups. Cell 1986. 45: 237-246.
20. De Libero, G., Casorati, G., Giachino, C., Carbonara, C., Migone, N., Matzinger, P. and Lanzavecchia, A., Selection by two powerful antigens may account for the presence of the major population of human peripheral γ/δ T cells. J. Exp. Med. 1991. 173: 1311-1322.
21. Panchamoorty, G., McLean, J., Modlin, R. L., Morita, C. T., Ishikawa, S., Brenner, M. B. and Band, H., A predominance of the Vγ2/Vδ2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J. Immunol. 1991. 147: 3360-3369.
22. Pechold, K., Wesch, D., Schondelmaier, S. and Kabelitz, D., Primary activation of Vγ9-expressing γfδ T cells by Mycobacterium tuberculosis: requirement for Th1-type CD4 T cell help and inhibition by IL-10. J. Immunol. 1994. 152: 4984-4991.
23. Pfeffer, K., Shoel, B., Gulle, H., Kaufmann, S. H. E. and Wagner, H., Primary responses of human T cells to mycobacteria: a frequent set of γ/δ T cells are stimulated by protease-resistant ligands. Eur. J. Immunol. 1990. 20: 1175-1179.
24. Tanaka, Y., Sano, S., Nieves, E., De Libero, G., Rosa, D., Modlin, R. L, Brenner, M. B., Bloom, B. R. and Morita, C. T., Non-peptide ligands for human γδ T cells. Proc. Natl. Acad. Sci. USA 1994. 91: 8175-8179.
25. Schoel, B., Sprenger, S. and Kaufmann, S. H. E., Phosphate is essential for stimulation of Vγ9/Vδ2 T lymphocytes by mycobac-terial low molecular weight ligand. Eur J, Immunol. 1994. 24: 1886-1892.
26. Constant, P., Davodeau, F., Peyrat, M. A., Poquet, Y., Puzo, G., Bonneville, M. and Fournié, J. J., Stimulation of human γδ T cells by nonpeptide mycobacterial ligands. Science 1994. 264: 267-270.
27. Lang, F., Peyrat, M. A., Constant, P., Davodeau, F., David-Ameline, J., Poquet, Y., Vié, H., Fournié, J. J. and Bonneville, M., Early activation of human Vγ9/Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 1995. 154: 5986-5994.
28. Fisch, P., Meuer, E., Pende, D., Rothenfuber, S., Viale, O., Kock, S., Ferrone, S., Fradelizi, D., Klein, G., Moretta, L., Rammensee, H. G., Boon, T., Coulie, P. and van der Bruggen, P., Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 cells in tumor immunity. Eur. J. Immunol. 1997. 27: 3368-3379.
29. + αβ T cell and γδ T cell responses to Mycobacterium tuberculosis. J. Immunol. 1995. 154: 1786-1796.
30. Davodeau, F., Peyrat, M. A., Houde, I., Hallet, M. M., Vié, H. and Bonneville, M., Peripheral selection of antigen receptor junctional features in a major human γδ T cell subset. Eur. J. Immunol. 1993. 23: 804-810.
31. Aggarval, B. B. and Vilcek, J. (Eds.) Tumor necrosis factor: structure, function and mechanism of action. Marcel Dekker, New York 1992.
32. Nagata, S. and Suda, T., Fas and Fas ligand: lpr and gld mutations, Immunol. Today 1995. 16: 39-42.
33. Kagi, D., Vignaux, F., Ledermann, B., Burki, K., Depraetere, V., Nagata, S., Hengartner, H. and Goldstein, P., Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994. 265: 528-531.
34. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., and Bloom, B. R., Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 1992. 89: 12013-12017.
35. Behar, S. M., Dascher, C. C., Grusby, M. J., Wang, C. R. and Brenner, M. B., Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 1999. 189: 1973-1980.
36. Nagata, S. and Goldstein, P., The Fas death factor. Science 1995. 267: 1449-1451.
37. Li, B., Rossman, M. D., Imir, T., Oner-Eyuboglu, A. F., Lee, C. W., Biancaniello, R. and Carding, S. R., Disease-specific changes in γδ T cell repertoire and function in patients with pulmonary tuberculosis. J. Immunol. 1996. 157: 4222-4229.
38. Oddo, M., Renno, T., Attinger, A., Bakker, T., MacDonald, H. R. and Meylan, P. R. A., Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 1998. 160: 5448-5454.
39. + HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein. Eur. J. Immunol. 1990. 20: 369-376.
40. + T cells use both CD95-dependent and CD95-independent cytolytic mechanisms. J. Immunol. 1998. 160: 2374-2379.
41. Li, B., Bassiri, H., Rossman, M. D., Kramer, P., Eyuboglu, A. F., Torres, M., Sada, E., Imir, T. and Carding, S. R., Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human 70 T cells: a mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis. J. Immunol. 1998. 161: 1558-1567.
42. Laochumroonvorapong, P., Wang, J., Liu, C. C., Ye, W., Moreira, A. L., Elkon, K. B., Freedman, V. H. and Kaplan, G., Perform, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect. Immun. 1997. 65: 127-132.
43. Cooper, A. M., O'Souza, C., Frank, A. A. and Orme, I. M., The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin-or granzyme-mediated cytolytic mechanisms. Infect. Immun. 1997. 65: 1317-1320.
44. Elloso, M. M., Heyd, H. C., Vande Waa, J. A., Manning, D. D. and Weidanz, W. P., Inhibition of Plasmodium falciparum in vitro by human γδ T cells. J. Immunol. 1994. 153: 1187-1194.
45. Troye-Blomberg, M., Worku, S., Tangteerawatana, P., Jamshaid, R., Soderstrom, K., ElGhazali, G., Moretta, L., Hammarstrom, M. L. and Mincheva-Nilsson, L., Human γδ T cells that inhibit the in vitro 19 growth of the asexual blood stage of Plasmodium falciparum parasite express cytolytic and proinflammatory molecules. Scand. J. Immunol. 1999. 50: 642-650.
46. Sireci, G., Champagne, E., Fournie, J. J., Dieli, F. and Salerno, A., Patterns of phosphoantigen stimulation of human Vγ9/Vδ2 T cell clones include Th0 cytokines. Hum. Immunol. 1997. 58: 70-82.
47. Dieli, F., Sireci, G., Di Sano, C., Champagne, E., Fournie, J. J., Ivanyi, J. and Salerno, A., Predominance of Vγ9/Vδ2 lympho-cytes in the cerebrospinal fluid of children with tuberculous meningitis: reversal after chemotherapy. Mol. Med. 1999. 5: 301-412.
48. Belmant, C., Espinosa, E., Poupot, R., Peyrat, M. A., Guiraud, M., Poquet, Y., Bonneville, M. and Fournié, J. J., 3-formyl-1-butyl-pirophosphate: a novel mycobacterial metabolite activating human γδ T cells. J. Biol. Chem. 1999. 274: 32079-32084.
49. Dieli, F., Friscia, G., Di Sano, C., Ivanyi, J., Singh, M., Spallek, R., Sireci, G., Titone, L. and Salerno, A., Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J. Infect. Dis. 1999. 180: 225-228.